Titre : Paraparésie spastique tropicale

Paraparésie spastique tropicale : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Paraparésie spastique tropicale : Questions médicales les plus fréquentes", "headline": "Paraparésie spastique tropicale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Paraparésie spastique tropicale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-23", "dateModified": "2024-11-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Paraparésie spastique tropicale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Myélite", "url": "https://recherchemedicale.com/mesh/D009187", "about": { "@type": "MedicalCondition", "name": "Myélite", "code": { "@type": "MedicalCode", "code": "D009187", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.586.750" } } }, "about": { "@type": "MedicalCondition", "name": "Paraparésie spastique tropicale", "alternateName": "Paraparesis, Tropical Spastic", "code": { "@type": "MedicalCode", "code": "D015493", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yoshihisa Yamano", "url": "https://recherchemedicale.com/author/Yoshihisa%20Yamano", "affiliation": { "@type": "Organization", "name": "Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan." } }, { "@type": "Person", "name": "Tomoo Sato", "url": "https://recherchemedicale.com/author/Tomoo%20Sato", "affiliation": { "@type": "Organization", "name": "Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan." } }, { "@type": "Person", "name": "Naoko Yagishita", "url": "https://recherchemedicale.com/author/Naoko%20Yagishita", "affiliation": { "@type": "Organization", "name": "Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan." } }, { "@type": "Person", "name": "Natsumi Araya", "url": "https://recherchemedicale.com/author/Natsumi%20Araya", "affiliation": { "@type": "Organization", "name": "Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan." } }, { "@type": "Person", "name": "Junji Yamauchi", "url": "https://recherchemedicale.com/author/Junji%20Yamauchi", "affiliation": { "@type": "Organization", "name": "Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Performance, HSP70 expression, antioxidant enzymes, oxidative DNA damage biomarkers, metabolic hormones, and intestinal microbiota of broiler chickens fed mistletoe leaf powder supplemented diets under tropical high ambient temperatures.", "datePublished": "2024-05-03", "url": "https://recherchemedicale.com/article/38714146", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jtherbio.2024.103861" } }, { "@type": "ScholarlyArticle", "name": "Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Tropical Medicine and International Health (SETMSI), on the diagnostic and treatment of imported schistosomiasis.", "datePublished": "2023-05-23", "url": "https://recherchemedicale.com/article/37230838", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.eimce.2023.02.008" } }, { "@type": "ScholarlyArticle", "name": "Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial.", "datePublished": "2022-05-19", "url": "https://recherchemedicale.com/article/35598604", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2352-3026(22)00113-2" } }, { "@type": "ScholarlyArticle", "name": "[Mortality from neglected tropical ciseases in Brazil in the 21st Century: Analysis of spatial and temporal trends and associated factorsMortalidad por enfermedades tropicales desatendidas en Brasil en el siglo XXI: análisis de tendencias espaciales y temporales y factores asociados].", "datePublished": "2023-10-24", "url": "https://recherchemedicale.com/article/37881800", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26633/RPSP.2023.146" } }, { "@type": "ScholarlyArticle", "name": "Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM).", "datePublished": "2022-06-11", "url": "https://recherchemedicale.com/article/35697179", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijantimicag.2022.106611" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://recherchemedicale.com/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Myélite", "item": "https://recherchemedicale.com/mesh/D009187" }, { "@type": "ListItem", "position": 4, "name": "Paraparésie spastique tropicale", "item": "https://recherchemedicale.com/mesh/D015493" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Paraparésie spastique tropicale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Paraparésie spastique tropicale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Paraparésie spastique tropicale", "description": "Comment diagnostiquer la paraparésie spastique tropicale ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels symptômes initiaux peuvent indiquer cette maladie ?\nLe diagnostic peut-il être confondu avec d'autres maladies ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://recherchemedicale.com/mesh/D015493?page=334#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Paraparésie spastique tropicale", "description": "Quels sont les symptômes principaux de la paraparésie spastique tropicale ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nY a-t-il des symptômes associés à des infections spécifiques ?\nLes symptômes sont-ils réversibles ?\nComment les symptômes évoluent-ils dans le temps ?", "url": "https://recherchemedicale.com/mesh/D015493?page=334#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Paraparésie spastique tropicale", "description": "Comment prévenir la paraparésie spastique tropicale ?\nLes vaccinations peuvent-elles aider ?\nQuelles mesures d'hygiène sont recommandées ?\nL'éducation sur le VIH est-elle importante ?\nLes tests réguliers pour le VIH sont-ils conseillés ?", "url": "https://recherchemedicale.com/mesh/D015493?page=334#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Paraparésie spastique tropicale", "description": "Quels traitements sont disponibles pour cette condition ?\nLa physiothérapie est-elle efficace ?\nQuels médicaments sont souvent prescrits ?\nY a-t-il des traitements expérimentaux ?\nLe soutien psychologique est-il nécessaire ?", "url": "https://recherchemedicale.com/mesh/D015493?page=334#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Paraparésie spastique tropicale", "description": "Quelles complications peuvent survenir ?\nLa paraparésie peut-elle entraîner des problèmes psychologiques ?\nLes complications sont-elles évitables ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être gérées ?", "url": "https://recherchemedicale.com/mesh/D015493?page=334#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Paraparésie spastique tropicale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de paraparésie ?\nLes voyages dans des zones tropicales augmentent-ils le risque ?\nY a-t-il des prédispositions génétiques ?\nLe mode de vie influence-t-il le risque ?", "url": "https://recherchemedicale.com/mesh/D015493?page=334#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la paraparésie spastique tropicale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen neurologique, l'imagerie cérébrale et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des IRM, des électromyogrammes et des analyses de sang pour détecter des infections." } }, { "@type": "Question", "name": "Quels symptômes initiaux peuvent indiquer cette maladie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des faiblesses musculaires progressives et des spasmes dans les jambes sont fréquents." } }, { "@type": "Question", "name": "Le diagnostic peut-il être confondu avec d'autres maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec la sclérose en plaques ou d'autres neuropathies." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des infections antérieures ou des facteurs de risque." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux de la paraparésie spastique tropicale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse des jambes, spasmes musculaires et troubles de la marche." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la combinaison des symptômes peuvent varier selon les individus." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des infections spécifiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre peuvent indiquer une infection sous-jacente, comme le VIH." } }, { "@type": "Question", "name": "Les symptômes sont-ils réversibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certains symptômes peuvent s'améliorer avec un traitement, mais d'autres peuvent persister." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils dans le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver progressivement, nécessitant une surveillance continue." } }, { "@type": "Question", "name": "Comment prévenir la paraparésie spastique tropicale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par la réduction des risques d'infections, notamment le VIH." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent réduire le risque d'infections qui mènent à cette condition." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène personnelle et éviter les contacts à risque sont essentiels." } }, { "@type": "Question", "name": "L'éducation sur le VIH est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation sur le VIH et les pratiques sexuelles sûres est cruciale pour la prévention." } }, { "@type": "Question", "name": "Les tests réguliers pour le VIH sont-ils conseillés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests réguliers peuvent aider à détecter le VIH tôt et à prévenir des complications." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour cette condition ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la physiothérapie, les médicaments antispasmodiques et le soutien psychologique." } }, { "@type": "Question", "name": "La physiothérapie est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie aide à améliorer la mobilité et à réduire les spasmes musculaires." } }, { "@type": "Question", "name": "Quels médicaments sont souvent prescrits ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme le baclofène ou la tizanidine sont couramment utilisés pour réduire les spasmes." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur des thérapies géniques et des traitements antiviraux." } }, { "@type": "Question", "name": "Le soutien psychologique est-il nécessaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien psychologique est important pour aider les patients à faire face à la maladie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles de la mobilité, des douleurs chroniques et des infections secondaires." } }, { "@type": "Question", "name": "La paraparésie peut-elle entraîner des problèmes psychologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent développer de l'anxiété ou de la dépression en raison de leur condition." } }, { "@type": "Question", "name": "Les complications sont-elles évitables ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées avec un traitement précoce et approprié." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant l'autonomie et les activités quotidiennes." } }, { "@type": "Question", "name": "Les complications peuvent-elles être gérées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avec un suivi médical et des traitements adaptés, de nombreuses complications peuvent être gérées." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'infection par le VIH, des antécédents d'infections tropicales et des prédispositions génétiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de paraparésie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes plus âgées peuvent avoir un risque accru en raison de la dégradation musculaire." } }, { "@type": "Question", "name": "Les voyages dans des zones tropicales augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des zones tropicales exposent à des infections pouvant causer cette maladie." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines personnes peuvent avoir une prédisposition génétique à développer des troubles neurologiques." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie à risque, comme des pratiques sexuelles non protégées, augmente le risque d'infection." } } ] } ] }

Sources (3336 au total)

Performance, HSP70 expression, antioxidant enzymes, oxidative DNA damage biomarkers, metabolic hormones, and intestinal microbiota of broiler chickens fed mistletoe leaf powder supplemented diets under tropical high ambient temperatures.

The study investigated the impact of Mistletoe Leaf Powder (MLP) supplementation on some parameters in heat-stressed broiler chickens. The standard baseline diets, comprising four different formulatio...

Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Tropical Medicine and International Health (SETMSI), on the diagnostic and treatment of imported schistosomiasis.

Schistosomiasis is a highly prevalent disease, especially in immigrant populations, and is associated with significant morbidity and diagnostic delays outside endemic areas. For these reasons, the Spa...

Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial.

A novel, engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX (FIX) protein (BBM-H901) has been developed and is promising for haemophilia B gene therapy. We... We did a single-centre, single-arm, phase 1, pilot trial evaluating the safety and activity of a single intravenous infusion of BBM-H901 at the Institute of Hematology & Blood Diseases Hospital, Chine... Between Oct 16, 2019, and Jan 13, 2021, 12 male participants were assessed, and ten Chinese participants were enrolled and infused with BBM-H901. After a median follow-up of 58 weeks (IQR 51·5-99·5), ... This pilot study suggests that liver-tropic BBM-H901 is safe 1 year after infusion. Vector derived FIX:C concentration is sufficiently high to prevent bleeding events and minimise the need for replace... Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China, Tianjin Municip...

[Mortality from neglected tropical ciseases in Brazil in the 21st Century: Analysis of spatial and temporal trends and associated factorsMortalidad por enfermedades tropicales desatendidas en Brasil en el siglo XXI: análisis de tendencias espaciales y temporales y factores asociados].

To analyze the spatial-temporal distribution and factors associated with mortality from neglected tropical diseases (NTDs) in Brazil from 2000 to 2019.... We performed an ecological study to analyze NTD-related deaths recorded in the Ministry of Health Mortality Information System (SIM). For the temporal analysis, the joinpoint method was used. Spatial ... The mean mortality rate from NTDs in Brazil during the study period was 3.32 deaths per 100 000 inhabitants, with the highest rate (8.68 deaths per 100 000 inhabitants) recorded in the Midwest. The mo... Lower human development and higher social vulnerability are associated with higher mortality from NTDs, which should guide NTD prevention and control efforts....

Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM).

Management of patients with infections caused by multidrug-resistant organisms is challenging and requires a multidisciplinary approach to achieve successful clinical outcomes. The aim of this paper i...

Executive Summary of the Spanish Guidelines for the Diagnosis and Management of Imported Febrile Illnesses from the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Imported Pathology Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (GEPI-SEIMC), the Spanish Society of Family and Community Medicine (SEMFYC), the Spanish Society of Primary Care Physicians (SEMERGEN) and the Spanish Society of Emergency Medicine (SEMES).

The Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Emergency Medicine (SEM...